Sleep Clinical Trial
Official title:
The Effect of Laughter Yoga on Vasomotor Symptoms and Sleep Quality in Menopausal Women
| NCT number | NCT05859594 |
| Other study ID # | 246 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | May 2, 2023 |
| Est. completion date | August 31, 2023 |
| Verified date | September 2023 |
| Source | Mersin University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The research was planned as a prospective, randomized controlled experimental study to determine the effect of online laughter yoga applied to menopausal women on vasomotor symptoms (VMS) and sleep quality. Research Hypotheses ar below; H0: Online laughter yoga has no effect on VMS. H1: Online laughter yoga has an effect on VMS. H0: Online laughter yoga has no effect on sleep quality. H1: Online laughter yoga has an effect on sleep quality.
| Status | Completed |
| Enrollment | 36 |
| Est. completion date | August 31, 2023 |
| Est. primary completion date | July 31, 2023 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 40 Years to 60 Years |
| Eligibility | Inclusion Criteria: - - enrolled in the Menopause School, - Signing the Informed Consent Form, - Willing to participate in the research, - Able to read and write Turkish, - Open to communication, - Those who are between the ages of 40-60 and have not experienced menstruation for at least one year, - Experiencing at least one of the vasomotor symptoms - A VMS severity of at least 4 according to the Visual Analog Scale, - Not using drugs for the treatment of vasomotor symptoms, - No chronic disease - Regular laughter yoga is not practiced, - Those who have not entered the menopause surgically, - Women without psychiatric problems Exclusion Criteria: - - Not enrolled in Menopause School, - Not signing the Informed Consent Form, - Not willing to participate in the research, - Cannot read and write Turkish, - Unable to communicate - Less than 40 years old, over 60 years old, experienced menstruation for at least one year, - Not experiencing vasomotor symptoms, - VMS severity is less than 4 according to the Visual Analog Scale, - Using drugs for the treatment of vasomotor symptoms, - Having a chronic disease, - Regular laughter yoga practice - Those who have surgically entered the menopause, - Women with psychiatric problems |
| Country | Name | City | State |
|---|---|---|---|
| Turkey | Mersin University | Yenisehir | Mersin |
| Lead Sponsor | Collaborator |
|---|---|
| Mersin University |
Turkey,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Visual Analog Scala (VAS) | The Visual Analog Scale is used to measure the pain perceived by the person. There is a 10 cm mark on the one end of the scale, where there is no pain (zero), and on the other end there is the most severe (10) pain. Between the (100 mm.) part, the individual can indicate his or her pain by drawing a line, putting a dot or pointing. The distance from the point where there is no pain to the point marked by the individual is measured in centimeters, and the value found indicates the severity of the individual's pain. In this study, VAS will be used for hot flashes, night sweats and sweating experienced by women. Women will indicate where their situation is appropriate on this line by drawing a line or by placing a dot/mark. | change from baseline, at the end of 4th week of intervention. | |
| Secondary | Sleep quality | The Pittsburgh Sleep Quality Index (PUKI) will be used to assess sleep quality. PUKI sleep quality; subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping pills, and daytime dysfunction. Those with a total score above five on the PUKI are considered "poor", and those with a score of five or below are considered "good". | change from baseline, at the end of 4th week of intervention. |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
| Recruiting |
NCT06079853 -
Nurse Suicide: Physiologic Sleep Health Promotion Trial
|
N/A | |
| Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
| Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT04513743 -
Ultra Long-Term Sleep Monitoring Using UNEEG™ Medical 24/7 EEG™ SubQ
|
N/A | |
| Completed |
NCT03251274 -
Bath Machine on Sleep Quality in Nursing Home
|
N/A | |
| Completed |
NCT04102345 -
Lavender vs Zolpidem Sleep Quality During Diagnostic PSG
|
Early Phase 1 | |
| Completed |
NCT03725943 -
Comparison of Dreem to Clinical PSG for Sleep Monitoring in Healthy Adults
|
N/A | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Completed |
NCT04562181 -
Consistency Evaluation of the qCON, qNOX Indices and Bispectral Index
|
N/A | |
| Completed |
NCT05102565 -
A Dyadic Telehealth Program for Alzheimer's Patients/Caregivers
|
N/A | |
| Completed |
NCT05576844 -
Ai Youmian (Love Better Sleep) for People Living With HIV
|
N/A | |
| Completed |
NCT04688099 -
Synovial Fluid Sleep Study
|
||
| Recruiting |
NCT04171245 -
Prescribing Laughter for Sleep and Wellbeing in UAE University Students
|
N/A | |
| Completed |
NCT03758768 -
The Effects of a Blue Monochromatic Light Intervention on Evening-type Individuals' Sleep and Circadian Rhythms
|
N/A | |
| Completed |
NCT03163498 -
Evaluation of Sleep Pattern and Mood Profile in Hypertensive Patients
|
||
| Completed |
NCT04093271 -
Investigating the Efficacy of Rest-ZZZ Formula in Healthy Participants With Difficulty Falling Asleep or Staying a Sleep
|
Phase 1 | |
| Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
| Completed |
NCT04120363 -
Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations
|
Phase 4 |